Marlana M. Orloff, MD, offers advice for patients who are diagnosed with metastatic uveal melanoma.
Transcript:
What advice do you have for patients and caregivers of those recently diagnosed with uveal melanoma?
Marlana M. Orloff, M.D.: Because metastatic uveal melanoma is so rare, it’s very important that patients seek a provider who’s familiar with the treatment landscape.One of the other things patients with uveal melanoma can do when they’re first diagnosed is seek out information provided by patient advocacy organizations.
Now that Kimmtrak [tebentafusp] has been approved for metastatic uveal melanoma, it has really brought to light a lot of the differences between uveal melanoma and skin melanoma, and the need for additional treatments. Specifically, there’s a huge unmet need that remains for patients who are HLA-A*02:01 negative. I’m happy to say that there are a number of ongoing clinical trials looking at new treatment options. Having an FDA-approved therapy has also brought greater awareness to this rare melanoma subtype.
Thank you for joining me to learn about uveal melanoma. We hope you found this Educated Patient Sound Bites program to be informative.
Transcript edited for clarity.
Olivia Munn Discusses Breast Cancer, Christine Brinkley Diagnosed With Basal Cell Carcinoma and More
March 15th 2024From Oliva Munn and Christine Brinkley discussing their cancer to Donnie Iris returning to the stage after his experience with the disease, here is what’s happening in the oncology space this week.
Read More
Weeks of TIL Therapy ‘Buys Years’ to Next Melanoma Treatment, Expert Says
February 22nd 2024Treatment with Amtagvi, a TIL therapy recently approved for advanced melanoma, includes a three-week hospital stay upfront, but may lead to years of monitoring without more treatment needed, an expert explained.
Read More
Rare Immune Cell May Predict Immunotherapy Response in Melanoma
January 7th 2024Vd1-gd T cells, a rare type of immune cell, have been found to potentially predict how likely it is that certain patients with advanced skin cancer will be responsive to treatment via immunotherapy, according to recently published research.
Read More